A new hormone treatment could help men placed at risk by low testosterone levels, researchers say today.
The treatment could help men at risk of heart disease because of this problem, according to Scottish researchers.
Currently, low testosterone is treated by giving testosterone injections or gels, but this can lead to abnormally high levels and risk temporary infertility, mood changes, and acne, among other side-effects.
The researchers, from Edinburgh University, UK, say newly-developed hormone based treatments could be highly effective. In their studies, male testosterone levels increased after taking a hormone called kisspeptin. The hormone is also produced naturally in the body.
The hormone was discovered in Hershey, Pennsylvania, USA, and is named after a chocolate bar produced there.
Dr Jyothis George and colleagues based their research on earlier findings linking low testosterone and type-2 diabetes, which also raises heart disease risk.
They recruited five men with diabetes and low testosterone levels. The participants’ average age was 34 years. Kisspeptin was given through a drip over 12 hours. The effect of raising kisspeptin levels in the blood was to trigger testosterone production, but not to raise it above the normal healthy range.
Findings are published in the journal Clinical Endocrinology today (January 2).
Dr George said: "We know that low testosterone leads to an increased risk of heart disease. This treatment shows that kisspeptin can stimulate the body’s own production of testosterone, without testosterone levels becoming too high. We hope that, with further research, kisspeptin could potentially be used to treat testosterone deficiency."
The team now hope to undertake a larger study with more participants, to confirm the effectiveness of kisspeptin, as well as alternative ways of administering the hormone such as slow-release injections under the skin which would extend the beneficial effect.
George, J. T. et al. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: Kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clinical Endocrinology January 2 2012 doi: 10.1111/cen.12103

Leave a Reply